Membrane-stabilizing properties of Viburnum opulus fruit liquid extract and cardioprotective effect of tablets based on it
DOI:
https://doi.org/10.24959/nphj.23.118Keywords:
viburnum opulus fruit liquid extract (VOFLE),Abstract
Aim. To study the membrane-stabilizing properties of Viburnum opulus fruit liquid extract (VOFLE) and the cardioprotective activity of “Viburnikor” tablets developed on the basis of VOFLE.
Materials and methods. Membrane-stabilizing properties of VOFLE were studied according to the Jager F.C. method in rats with determination of the spontaneous hemolysis degree caused by peroxide oxidation of erythrocyte membranes lipids. VOFLE (50, 100, 150 mg/kg), reference drugs Quercetin (200 mg/kg) and vitamin E (50 mg/kg) were administered to animals intragastrically (i/g) for 7 days. Adrenaline myocardiodystrophy was reproduced in rats by a single subcutaneous injection of adrenaline hydrochloride (0.18 % solution) in the dose of 0.5 mg/kg (0.28 ml/kg) of the body weight. Thirty (30) white male rats with an initial weight of 230-270 g, aged 6-6.5 months were used in the experiment. “Viburnikor” tablets (100 and 150 mg/kg of the VOFLE content) and Quercetin (200 mg/kg) were administered i/g for 7 days, the last time 1 hour before the cardiotoxin administration. The activity of the drugs was evaluated by the survival of animals, the functional state of the myocardium (ECG studies), the effect on the heart mass ratio, the activity of aspartate aminotransferase (AST), the level of active products interacting with thiobarbituric acid (TBA-AP), the content of reduced glutathione (RG) and catalase activity in the heart homogenate.
Results and discussion. The VOFLE studied showed the most pronounced membrane-stabilizing effect in the doses of 100 and 150 mg/kg, respectively, 22 and 34 %, the intensity of which was not inferior to the reference drugs Quercetin (26 %) and vitamin E (28 %). On the model of catecholamine myocardiodystrophy, “Viburnikor” tablets (100 and 150 mg/kg) contributed to the improvement of the heart function, as evidenced by the normalization of electrocardiographic parameters and heart mass ratio to the level of intact animals. It has been shown that the cardioprotective properties of “Viburnikor” tablets are exhibited by detecting anticytolic (decrease in the AST activity to the level of intact control) and antioxidant action (decrease in the level of TBA-AP in the myocardium of animals by 31 % (p<0.05) and 33 % (p<0.05), respectively, and a 1.6- and 1.7-fold increase in RG (p<0.05) and catalase (p<0.05) versus the control pathology).
Conclusions. It has been proven that the most pronounced membrane-stabilizing effect of the VOFLE studied is in the doses of 100 and 150 mg/kg. Cardioprotective properties of “Viburnikor” tablets have been determined on the model of catecholamine myocardiodystrophy by revealing anticytolic and antioxidant effects. By the intensity of the membrane-stabilizing and cardioprotective activity of the drugs studied, VOFLE and “Viburnikor” tablets are not inferior to the reference drugs.
References
Bachheti, R. K., Worku, L. A., Gonfa, Y. H., Zebeaman, M., Pandey, D. P., Bachheti, A. (2022). Prevention and treatment of cardiovascular diseases with plant phytochemicals: A review. Evidence-Based Complementary and Alternative Medicine, 2022, ID 5741198, 21. doi: https://doi.org/10.1155/2022/5741198
Pop, R. M., Popolo, A., Trifa, A. P., Stanciu, L. A. (2018). Phytochemicals in cardio-vascular and respiratory diseases: evidence in oxidative stress and inflammation. Oxidative Medicine and Cellular Longevity, 2018, ID 1603872, 3. doi: 10.1155/2018/1603872.
Vasanthi, H., Shrishrimal, N., Das, D. (2012). Phytochemicals from plants to combat cardiovascular disease. Current Medicinal Chemistry, 19 (14), 2242–2251. doi: 10.2174/092986712800229078.
Thomford, N., Senthebane, D., Rowe, A., Munro, D., Seele, P., Maroyi, A. Et al. (2012). Phytochemicals from plants to combat cardiovascular disease. Current Medicinal Chemistry, 19 (14), 2242–2251. doi: 10.2174/092986712800229078.
Nosal, M. A., Nosal, I. M. (2013). Medicinal plants and methods of their use among the people. Kyiv.
Shpychak O. S., Yaroshenko A. O., Hvorost O. P., Skrebtsova K. S. (2022). U.S. Pat. No. 150941. Kharkiv.
Chekman, I. S., Belenichev, I. F., Gorchakova, N. A., Kucherenko, L. I., Bukhtiyarova, N. V., Pogotova, G. A. (2014). Antioxidants: clinical and pharmacological aspect. Ukrainian medical journal, 1 (99), 36-39.
Kozhem’yakin, Yu. M., Khromov, O. S., Filonenko, M. A., Saifetdinova, G. A. (2002). Scientific and practical recommendations for keeping laboratory animals and working with them. Kyiv : Avicenna.
Commission of the European Communities: Council Directive of 18 December 1986 on the Lows, regulating the Application of Principles of Good Laboratory Practice and the Verifica-tion of Their Applications for Tests on Chemical Substances (87/18/EEC). (1991). The Rules Govern-ing Medicinal Products in the European Community. Vol. 1, 145-146.
Stefanov, O. V. (2001). Preclinical research of medicines. Kyiv : Avicenna.
Medicines. Good laboratory practice. (2009). Kyiv : Ministry of Health of Ukraine.
Zaichenko, G. V., Mishchenko, O. Ya., Sharifov, H. Sh., Khaleeva, O. L. (2019). Medi-cines for humans. Modern problems of pharmacotherapy and drug prescription : materials of the 3rd international science and practice conf. (March 14-15, 2019). Kharkiv : NFaU.
Quertin – a complex effect on coronary heart disease. (2019). Medical newspaper «Health of Ukraine of the 21st Century», 12 (457). Available at: https://health-ua.com/article/43335-kvertin--kompleksnij-vpliv-na-shemchnu-hvorobu-sertcya
Nair, A. B., Jacob, S. (2016). A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm, 7(2), 27–31.
Symonenko, N., Shpychak, O. Mishchenko, O., Kyslychenko, V., Shpychak, T., Graschenkova, S. (2022). Antioxidant and anticytolytic activity of Parsnip (Pastinaca sativa L.) herb thick extract in conditions of catecholamine myocardiodystrophy in rats. ScienceRise: Pharmaceuti-cal Science,1 (35), 70–76.
Bondarenko, Ya. S., Kravchenko, S. V. (2018). Guide to studying the discipline «Sta-tistical data analysis». Dnipro : Lyra.
Boland, T. A., Lee, V. H., Bleck T. P. (2015). Stress-induced cardiomyopathy. Crit. Care Med, 43 (3), 686–693.
Wallner, M., Duran, J. M., Mohsin, S., Troupes, C. D., Vanhoutte, D., Borghetti, G. et al. (2016). Acute catecholamine exposure causes reversible myocyte injury without cardiac regenera-tion. Circulation Research, 119 (7), 865–879. doi: 10.1161/CIRCRESAHA.116.308687
Wang, A. R., Dean, S. A., Grebe, S. K., Hood, I. C. (2016). Fatal catechola-mine-induced cardiotoxicity associated with pheochromocytoma: Report of a postpartum case and review of the literature. Acad. Forensic Pathol, 6 (2), 315-324.
Khara, M. R., Shkumbatyuk, O. V., Kuchyrka, L. I. (2014). Characterization of the de-gree of damage to the myocardium by adrenaline in rats of different sexes depending on the duration of observation and the level of sex hormones. Bulletin of morphology, 20 (2), 372-375.
Omerovic, E. (2011). How to think about stress-induced cardiomyopathy? – Think “out of the box”! Scand. Cardiovasc. J., 45 (2), 67–71.
Bezkorovaina, G. O., Klish, I. M., Hara, M. R. (2019). Gender differences in free radi-cal processes in the myocardium during damage by adrenaline against the background of light depri-vation. Medicinal and Clinical Chemistry, 21 (4), 13–19.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
